George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 151.90
Bid: 153.40
Ask: 153.70
Change: 0.70 (0.46%)
Spread: 0.30 (0.196%)
Open: 155.00
High: 162.30
Low: 151.50
Prev. Close: 151.20
AML Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission of shares and total voting rights

2 Nov 2023 08:00

RNS Number : 1147S
Aston Martin Lagonda Glob.Hldgs PLC
02 November 2023

2 November 2023

Aston Martin Lagonda Global Holdings plc

("Aston Martin" or the "Company")

Progress to completion of Lucid Transaction and Admission of Consideration SharesTotal Voting Rights

Further to its announcement on 19 September 2023 confirming the receipt of shareholder approvals in connection with the strategic supply arrangement with Lucid Group, Inc. ("Lucid") (the "Transaction"), Aston Martin is today pleased to announce that clearance from all applicable regulatory and antitrust authorities has been obtained and the Transaction can proceed to completion.

Accordingly, the Company announces that, subject and pursuant to the previously disclosed terms of the Transaction:

· 28,352,273 new ordinary shares of £0.10 each in its share capital (the "Consideration Shares") will be allotted and issued to Lucid's subsidiary, Atieva, Inc.

· Integration and supply agreements between Aston Martin and Lucid governing Aston Martin's access to certain of Lucid's industry-leading technologies, including electric powertrains and battery systems, will become effective from Admission of the Consideration Shares

Applications have been made to the Financial Conduct Authority (the "FCA") and the London Stock Exchange plc (the "LSE") respectively for the admission of the Consideration Shares to listing on the premium listing segment of the Official List of the FCA and to trading on the main market for listed securities of the LSE (together, "Admission"). It is expected that Admission will become effective at 8.00 a.m. on 6 November 2023.

In accordance with the FCA's Disclosure Guidance and Transparency Rules, the Company also notifies that, following Admission becoming effective, the total issued share capital of the Company will be 823,663,785 ordinary shares of £0.10 each with one voting right per share. There are no ordinary shares held in treasury.

Therefore, following Admission becoming effective, the total number of voting rights in the Company will be 823,663,785 and this figure should be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change of their interest in, the Company under the Disclosure Guidance and Transparency Rules.

Enquiries

Investors and Analysts

Robert Berg Director of Investor Relations +44 (0) 7833 080458

robert.berg@astonmartin.com

Ella South Investor Relations Analyst +44 (0) 7776 545420

ella.south@astonmartin.com

Media

Kevin Watters Director of Communications +44 (0)7764 386683

kevin.watters@astonmartin.com

Paul Garbett Head of Corporate & Brand Communications +44 (0)7501 380799

paul.garbett@astonmartin.com

Teneo

Harry Cameron +44 (0)20 7353 4200

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ALSFFFIILALLIIV
Date   Source Headline
8th Apr 20249:00 amRNSAnnual Report 2023 and Notice of AGM
28th Mar 20244:10 pmRNSDirector Declaration
22nd Mar 20248:28 amRNSAppointment of New Chief Executive Officer
13th Mar 20246:16 pmRNSSuccessful pricing of £1.15 billion refinancing
12th Mar 20243:33 pmRNSHolding(s) in Company
11th Mar 20247:36 amRNSLaunch of Notes Offering
4th Mar 20249:05 amRNSIssue of equity to satisfy share awards
28th Feb 20247:00 amRNSPreliminary Results year ended 31 December 2023
20th Dec 20239:32 amRNSHolding(s) in Company
20th Dec 20239:31 amRNSHolding(s) in Company
8th Nov 20233:46 pmRNSHolding(s) in Company
8th Nov 20233:41 pmRNSHolding(s) in Company
8th Nov 20238:00 amRNSHolding(s) in Company
7th Nov 20233:23 pmRNSHolding(s) in Company
3rd Nov 202310:18 amRNSDirector/PDMR Shareholding
2nd Nov 20238:00 amRNSAdmission of shares and total voting rights
1st Nov 20237:00 amRNS3rd Quarter Results
30th Oct 20237:00 amRNSDirectorate Change
3rd Oct 20232:14 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:13 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:10 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:10 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:07 pmRNSHolding(s) in Company
29th Sep 20237:00 amRNSIncreased investment by Yew Tree Consortium
19th Sep 202311:53 amRNSResult of Meeting
29th Aug 202312:01 pmRNSPublication of Circular and Notice of GM
4th Aug 20234:45 pmRNSHolding(s) in Company
4th Aug 20231:05 pmRNSDirector/PDMR Shareholding
4th Aug 202312:43 pmRNSDirector/PDMR Shareholding
4th Aug 202312:33 pmRNSDirector/PDMR Shareholding
4th Aug 202312:32 pmRNSDirector/PDMR Shareholding
4th Aug 202312:21 pmRNSHolding(s) in Company
1st Aug 20237:00 amRNSResult of Equity Issue
31st Jul 20234:41 pmRNSRetail Offer
31st Jul 20234:40 pmRNSProposed Share Placing
28th Jul 20237:00 amRNSAppointment of Non-executive Director
26th Jul 20232:49 pmRNSTotal Voting Rights
26th Jul 20237:00 amRNSHalf-year Report
14th Jul 202312:18 pmRNSHolding(s) in Company
10th Jul 20234:34 pmRNSReplacement Listing and Total Voting Rights
10th Jul 20238:56 amRNSAdditional Listing and Total Voting Rights
6th Jul 20238:16 amRNSHolding(s) in Company
3rd Jul 20237:00 amRNSAdmission of New Shares for Warrant exercise
27th Jun 20237:00 amRNSCapital Markets Day 2023
26th Jun 20237:00 amRNSAston Martin Lagonda and Lucid Group, Inc.
26th Jun 20237:00 amRNSAston Martin Lagonda and Mercedes-Benz AG
31st May 20239:18 amRNSHolding(s) in Company
30th May 202310:44 amRNSHolding(s) in Company
30th May 202310:39 amRNSHolding(s) in Company
30th May 20238:46 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.